Literature DB >> 11186674

Additional follow-up from the ABCD trial in patients with type 2 diabetes and hypertension.

R W Schrier, R O Estacio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11186674     DOI： 10.1056/nejm200012283432614

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  Lessons learned from prematurely terminated clinical trials.

Authors:  D Sica
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

Review 2.  Cyclo-oxygenase-2-specific inhibitors and cardiovascular morbidity.

Authors:  Luis M Ruilope; Antonio Coca; José R Banegas; Jose Luis Pablos; Manuel Luque
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

Review 3.  Calcium channel blockers versus other classes of drugs for hypertension.

Authors:  Jiaying Zhu; Ning Chen; Muke Zhou; Jian Guo; Cairong Zhu; Jie Zhou; Mengmeng Ma; Li He
Journal:  Cochrane Database Syst Rev       Date:  2022-01-09

Review 4.  Calcium channel blockers versus other classes of drugs for hypertension.

Authors:  Jiaying Zhu; Ning Chen; Muke Zhou; Jian Guo; Cairong Zhu; Jie Zhou; Mengmeng Ma; Li He
Journal:  Cochrane Database Syst Rev       Date:  2021-10-17

Review 5.  Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy.

Authors:  D M Rabi; N Khan; M Vallee; M A Hladunewich; S W Tobe; L Pilote
Journal:  Can J Cardiol       Date:  2008-06       Impact factor: 5.223

6.  First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.

Authors:  Ganmi Wang; Yujie Chen; Liangjin Li; Wenlu Tang; James M Wright
Journal:  J Hum Hypertens       Date:  2018-05-01       Impact factor: 3.012

Review 7.  Premature termination of clinical trials--lessons learned.

Authors:  D A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 May-Jun       Impact factor: 3.738

Review 8.  Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials.

Authors:  Sripal Bangalore; Robert Fakheri; Bora Toklu; Franz H Messerli
Journal:  BMJ       Date:  2016-02-11

Review 9.  The role of calcium antagonists in stroke prevention.

Authors:  William J Elliott; Armin Bandari
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-04       Impact factor: 3.738

10.  Blood pressure targets for hypertension in patients with type 2 diabetes.

Authors:  Wilbert S Aronow; Tatyana A Shamliyan
Journal:  Ann Transl Med       Date:  2018-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.